OUR BUSINESS
Mukka Proteins believes that we are one of the key players in the Fish Protein industry in India. In Fiscal 2022, of the total estimated revenue of the Indian fish meal and fish oil industry of ₹13,000 to ₹17,000 million, the revenue of our Company was ₹6,928.87 million thus, being a 45%- 50% contributor to the estimated revenue of the Indian fish meal and fish oil industry for the corresponding period.
Mukka Proteins IPO Subscription Status Today
| DATE | QIB | NII | RII | TOTAL |
|---|---|---|---|---|
| Day-1 | -- | -- | -- | -- |
| Day-2 | -- | -- | -- | -- |
| Day-3 | -- | -- | -- | -- |
Mukka Proteins is also amongst the first few Indian companies to have commercialized insect meal and insect oil (collectively “Insect Protein”) as an ingredient for aqua feed, animal feed, and pet food. Fish Protein and Insect Protein are hereinafter, collectively, referred to as “Animal Protein”.Our Company was originally formed as a partnership firm constituted under the Indian Partnership Act, of 1932 under the name “Mukka Sea Foods Industries” under a deed of partnership dated March 13, 2003.
MUKKA PROTEINS IPO DATE & PRICE BAND DETAILS
| IPO Open Date | February 29, 2024 |
|---|---|
| IPO Close Date | March 4, 2024 |
| IPO Size | Approx ₹224 Crores |
| IPO Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹26 to ₹28 Per Every Share |
| IPO Listing On | NSE and BSE |
| IPO Retail Quota | 35% |
| IPO QIB Quota | 50% |
| IPO NII Quota | 15% |
OBJECTS OF THE ISSUE
- Funding working capital requirements of our Company.
- Investment in our Associate, viz. Ento Proteins Private Limited, for funding its working capital requirements.
- General Corporate Purpose.
MUKKA PROTEINS MARKET LOT DETAILS
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 535 | ₹14,980 |
| Retail Maximum | 13 | 6,955 | ₹194,740 |
| S-HNI Minimum | 14 | 7,490 | ₹205,800 |
| B-HNI Minimum | 67 | 35,845 | ₹1,003,660 |
OUR PROMOTERS
- Kalandan Mohammed Haris
- Kalandan Mohammad Arif
- Kalandan Mohammed Althaf
Mukka Proteins IPO GMP TODAY LIVE RATES & KOSTAK RATES
| IPO GMP DATE | GMP PRICE | IPO PRICE | SUBJECT TO SAUDA RATE |
|---|---|---|---|
| Feb-25-2024 | 15 | ||
| Feb-26-2024 | -- | -- | -- |
| Feb-27-2024 | -- | -- | -- |
| Feb-28-2024 | - | -- | -- |
QUALITATIVE FACTOR
- Our position as a leading manufacturer and exporter of Fish Protein products.
- Established customer base and strong relationships.
- Strategically located processing facilities.
- Entry Barriers.
- Strong and consistent financial performance.
- Focus on Quality, Environment, Health and Safety (QEHS).
- Experienced Promoter Directors with extensive domain knowledge.
MUKKA PROTEINS IPO ALLOTMENT & LISTING DATE (DETAILS)
| Anchor Investor Allotment | Feb 28, 2024 |
|---|---|
| IPO Open Date | Feb 29, 2024 |
| IPO Close Date | March 4, 2024 |
| Basis of Allotment | March 5, 2024 |
| Refunds | March 6, 2024 |
| Credit to Demat Account | March 6, 2024 |
| IPO Listing Date | March 7, 2024 |
MUKKA PROTEINS FINANCIAL REPORTS
| ₹ in Crores | |||
|---|---|---|---|
| Year | Revenue | Expense | PAT |
| 2023 | ₹1183.80 | ₹1119.32 | ₹47.52 |
| 2022 | ₹776.14 | ₹741.18 | ₹25.82 |
| 2021 | ₹609.95 | ₹598.31 | ₹11.01 |
BASIC & DILUTED EARNINGS PER EQUITY SHARE (“EPS”)
| Financial Year Ended | Basic EPS (in ₹) | Diluted EPS (in ₹) | Weight |
|---|---|---|---|
| March 31, 2022 | 1.10 | 1.10 | 3 |
| March 31, 2021 | 0.41 | 0.41 | 2 |
| March 31, 2020 | 0.60 | 0.60 | 1 |
| Weighted Average | 0.79 | 0.79 |
MUKKA PROTEINS COMPANY CONTACT DETAILS
Mukka Corporate House
Door No. 18-2-16/4, First Cross, NG Road
Attavara, Dakshina Kannada
Mangaluru – 575001, Karnataka, India
Tel No: +91 8244252889
Email: cs@mukkaproteins.com
Investor Grievance ID: investors@mukkaproteins.com
Website: www.mukkaproteins.com
MUKKA PROTEINS IPO REGISTAR
Cameo Corporate Services Limited
Subramanian Building,
5th Floor No. 1 Club House Road
Chennai – 600 002, India
Tel: +914440 0207 00 (5 lines)
Email: priya@cameoindia.com
Investor Grievance Email: mukka@cameoindia.com
Website: www.cameoindia.com
Contact Person: K Sreepriya
MUKKA PROTEINS LEAD MANAGER
FedEx Securities Private Limited
B 7, 3rd Floor, Jay Chambers
Dayaldas Road, Vile Parle (East)
Mumbai Maharashtra – 400 057, India
Tel: +91 8104985249
E-mail: mb@fedsec.in
Website: www.fedsec.in
Investor Grievance E-mail: mb@fedsec.in
Contact Person: Saipan Sanghvi
